Лучшие больницы для «Aortic Valve Repair» в Хайдарабад, Индия

The all-inclusive cost of aortic valve repair in India typically ranges from USD 6,000 to USD 14,000, covering the surgeon's fee, anesthesiologist, ICU care, ward stay of 7–12 days, standard medications, cardiopulmonary bypass, prosthetic valve or repair materials, and a post-operative echocardiogram. In the UAE (Dubai or Abu Dhabi), the equivalent package ranges from USD 15,000 to USD 30,000 at JCI- and DHA-accredited private cardiac centers. India is therefore 40–60% less expensive than the UAE for the same clinical procedure — a saving of USD 9,000 to USD 16,000 — while maintaining internationally benchmarked surgical outcomes. Complex procedures such as valve-sparing root replacement (David operation), combined aortic valve and coronary bypass surgery, or redo-surgery will be priced at the upper end of these ranges. GAF Healthcare provides a fully itemized cost estimate specific to your surgical plan before any commitment is required.

Most patients are discharged from the hospital 7 to 12 days after surgery. However, discharge from the hospital does not mean fitness to fly. An international commercial flight — particularly a long-haul flight — poses specific post-cardiac-surgery risks including deep vein thrombosis (DVT) from prolonged immobility, expansion of any residual pleural or pericardial collections due to cabin pressure changes, and hemodynamic stress during altitude exposure. GAF Healthcare's affiliated surgeons follow international aviation medicine guidelines and typically clear patients for short-haul flights (under 4–5 hours) from approximately 4 weeks post-operatively, and for long-haul intercontinental flights (over 6 hours) from 6 to 8 weeks post-operatively. Fitness-to-fly is confirmed individually based on: clinical wound assessment (stable sternum, healed incision), echocardiographic confirmation of no significant pericardial effusion, INR within therapeutic range for anticoagulated patients, and absence of new arrhythmias. Patients with complications such as prolonged chest drainage, re-operation, stroke, or sternal dehiscence will require an extended stay. GAF Healthcare manages the entire post-discharge monitoring period and issues a formal fit-to-fly letter for airline documentation.

Aortic valve repair, when performed at high-volume specialist centers by experienced cardiac surgeons, achieves a procedural technical success rate of 95–98% — defined as residual aortic regurgitation that is none or trivial on intraoperative transesophageal echocardiography before chest closure. In-hospital mortality for isolated aortic valve repair in low-to-intermediate surgical risk patients (STS-PROM below 4%) is below 1–2% at leading centers. Long-term durability data from major repair programs (including those at institutions analogous in volume and expertise to GAF Healthcare's partner hospitals) demonstrate freedom from reoperation of approximately 85–90% at 10 years and 70–80% at 15 years for primary degenerative or bicuspid valve repair. For valve-sparing root replacement (David operation), 10-year freedom from reoperation exceeds 90% in expert hands. Ozaki neocuspidization (autologous pericardial reconstruction) shows 5-year freedom from reoperation exceeding 92% in published series. Outcomes are highly dependent on the surgeon's experience, the underlying etiology (rheumatic vs. degenerative vs. bicuspid), and the complexity of the repair. GAF Healthcare exclusively partners with cardiac surgeons who perform a minimum of 50 valve repair procedures annually and with hospitals that maintain full quality audit datasets — giving international patients access to verifiable, transparent outcomes data.